Head-to-Head: which drug lifts bipolar depression faster?
NCT ID NCT05913947
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether lithium or cariprazine works better for treating depression in people with bipolar disorder. About 122 adults will be randomly assigned to one of the two medicines for 8 weeks. Researchers will track mood changes, side effects, and lab results to see which drug provides more relief.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION, BIPOLAR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Aalborg University Hospital
RECRUITINGAalborg, 9000, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a psychedelic compound ease suicidal thoughts in bipolar depression?
- Brain stimulation study seeks clues to lasting depression relief
- 10-Year depression study aims to unlock personalized treatment clues
- Can a ketamine shot stop suicidal thoughts in minutes?
- Brain zapping showdown: which depression treatment wins?
- Parkinson's drug shows promise for Depression's pleasure loss